Transcriptional activation of p21WAF1by PTEN/MMAC1 tumr suppressor

被引:37
|
作者
Wu, RC
Li, X
Schönthal, A
机构
[1] Univ So Calif, Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
关键词
PTEN tumor suppressor; cyclin-dependent kinase inhibitors; apoptosis; chemosensitivity;
D O I
10.1023/A:1007024624967
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The recently discovered tumor suppressor gene PTEN has been found mutated in many types of advanced tumors. When introduced into tumor cells that lack the wild-type allele of the gene, PTEN was able to suppress the growth of these cells. Here, we have analyzed how PTEN might alter cell cycle-regulatory controls to achieve this growth-inhibitory effect. We found that overexpression of PTEN stimulates the synthesis of three inhibitors of cyclin-dependent kinases, p21(WAF1), p27(KIP1), and p57(KIP2). This effect is very specific, as the expression of other components of the cell cycle engine, various cyclins and cyclin-dependent kinases, is not affected. For p21(WAF1) we show that this induction is due to the p53-independent transcriptional activation of its promoter. In addition, increased expression of PTEN rendered the cells more sensitive to apoptotic cell death. Therefore, our data suggest a two-fold mechanism of growth inhibition by PTEN: one that acts via the increased expression of CKIs such as p21(WAF1), and another that augments the cellular propensity for apoptotic cell death.
引用
收藏
页码:59 / 71
页数:13
相关论文
共 50 条
  • [1] Transcriptional activation of p21WAF1by PTEN/MMAC1 tumr suppressor
    Ray-Chang Wu
    Xinwei Li
    Axel Schönthal
    Molecular and Cellular Biochemistry, 2000, 203 : 59 - 71
  • [2] Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN
    Fujii, GH
    Morimoto, AM
    Berson, AE
    Bolen, JB
    ONCOGENE, 1999, 18 (09) : 1765 - 1769
  • [3] Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN
    Gregory H Fujii
    Alyssa M Morimoto
    Amy E Berson
    Joseph B Bolen
    Oncogene, 1999, 18 : 1765 - 1769
  • [4] Suppression of tumorigenicity by MMAC1/PTEN
    Cheney, WI
    Johnson, D
    Vaillancourt, MT
    Avanzini, J
    Morimoto, A
    Demers, GW
    Wills, K
    Shabram, P
    Ramachandra, M
    Bolen, JB
    Tavtigian, S
    Bookstein, R
    CANCER GENE THERAPY, 1998, 5 (06) : S29 - S29
  • [5] PTEN/MMAC1 mutations in prostate cancer
    Müller M.
    Rink K.
    Krause H.
    Miller K.
    Prostate Cancer and Prostatic Diseases, 2000, 3 (Suppl 1) : S32 - S32
  • [6] Mutational analysis of the tumor suppressor gene PTEN/MMAC1 in breast carcinomas
    Sun, KS
    Na, SY
    Kim, JR
    Chang, ES
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S67 - S67
  • [7] Cowden disease and the PTEN/MMAC1 gene
    McIver, B
    Eberhardt, NL
    GENETICS OF COMPLEX THYROID DISEASES, 2002, : 151 - 175
  • [8] PTEN/MMAC1 mutations in hepatocellular carcinomas
    Ya Juan Yao
    Xiao Li Ping
    Hong Zhang
    Fei Fei Chen
    Patricia K Lee
    Habibul Ahsan
    Chien-Jen Chen
    Po-Huang Lee
    Monica Peacocke
    Regina M Santella
    Hui C Tsou
    Oncogene, 1999, 18 : 3181 - 3185
  • [9] Analysis of PTEN/MMAC1 alteration in neuroblastoma
    Moritake, H
    Horii, Y
    Kuroda, H
    Sugimoto, T
    CANCER GENETICS AND CYTOGENETICS, 2001, 125 (02) : 151 - 155
  • [10] PTEN/MMAC1 mutations in hepatocellular carcinomas
    Yao, YJ
    Ping, XL
    Zhang, H
    Chen, FF
    Lee, PK
    Ahsan, H
    Chen, CJ
    Lee, PH
    Pleacocke, M
    Santella, RM
    Tsou, HC
    ONCOGENE, 1999, 18 (20) : 3181 - 3185